| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/01/2004 | US20040127510 Arylindenopyridines and arylindenopyrimidines and related therapeutic and prophylactic methods |
| 07/01/2004 | US20040127508 Substituted pyrazolopyrimidines and thiazolopyrimidines |
| 07/01/2004 | US20040127506 Antimycobacterial compounds |
| 07/01/2004 | US20040127504 Administering benzimidazole compound for therapy of sexual dysfunction in a mammal |
| 07/01/2004 | US20040127503 17Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 07/01/2004 | US20040127502 Use of pyrimidine compound galanin receptor subtype 3 (GAL3) antagonists, which may be classified as neutral antagonists, inverse agonists or allosteric modulators, to treat depressive disorders and/or anxiety |
| 07/01/2004 | US20040127500 Inhibition of matrix metalloproteases by substituted biaryl oxobutyric acids |
| 07/01/2004 | US20040127499 For therapy and prophylaxis of diseases associated with pestivirus infection in mammalian hosts |
| 07/01/2004 | US20040127498 Heterocyclic side chain containing, n-substituted metalloprotease inhibitors |
| 07/01/2004 | US20040127496 Imidazole-2-carboxamide derivatives as raf kinase inhibitors |
| 07/01/2004 | US20040127495 Preferential suppressors of immunoglobulins, used as immunosuppressants and antiallergens |
| 07/01/2004 | US20040127494 Sulfur compounds such as (2R)-2-[N-(4-Chlorobenzenesulfonyl)-N-(4-methoxybenzyl)amino]-4-methylpentanoic acid amide, used for prophylaxis of neurodegenarative disorders such as Alzheimer's Disease and Down's Syndrome |
| 07/01/2004 | US20040127492 Cyclic pyrazoles for the inhibition of mitogen activated protein kinase-activated protein kinase-2 |
| 07/01/2004 | US20040127491 For therapy of diseases or disorders as diverse as those related to the cholinergic system of the central nervous system (CNS), the peripheral nervous system (PNS), diseases or disorders related to smooth muscle contraction, endocrine diseases |
| 07/01/2004 | US20040127490 Administering a therapeutic amount of an alprazolam, estazolam, midazolam or triazolam condensation aerosol for therapy of anxiety or insomnia |
| 07/01/2004 | US20040127489 Novel antipsychotic combination therapies and compositions useful therein |
| 07/01/2004 | US20040127485 1,4! - diazepane -1- carboxylic acid derivatives process for their preparation and their use as tachykinin antagonists |
| 07/01/2004 | US20040127482 Substituted heterocycle fused gamma-carbolines |
| 07/01/2004 | US20040127481 Administering a therapeutic amount of a lidocaine, verapamil, diltiazem, isometheptene, or lisuride condensation aerosol |
| 07/01/2004 | US20040127479 Peroxynitrite rearrangement catalysts |
| 07/01/2004 | US20040127476 For human and veterinary applications |
| 07/01/2004 | US20040127475 Applying to a medical device formulation comprising a sex hormone, anti-hormone, sex-hormone agonist, steroid-hormone inhibitor/antagonist (partial or full), selective estrogen receptor modulator; inserting medical device into living organism |
| 07/01/2004 | US20040127474 Contacting the cell with a ptc agonist in a sufficient amount to inhibit the altered growth state, wherein the ptc agonist is a organic molecule having a molecular weight less than about 750 amu for inhibiting an altered growth state of a cell |
| 07/01/2004 | US20040127472 Use of anecortave acetate for the protection of visual acuity in patients with age related macular degeneration |
| 07/01/2004 | US20040127471 Administering a therapeutically effective amount of at least one agent capable of inhibiting a neuronal cell cycle progression for therapy of age associated memory impairment, mild cognitive impairment (MCI), Alzheimer's disease |
| 07/01/2004 | US20040127470 Methods and compositions for the prevention or treatment of neoplasia comprising a Cox-2 inhibitor in combination with an epidermal growth factor receptor antagonist |
| 07/01/2004 | US20040127468 phosphatidic acid decreases apoptosis induced by the sudden withdrawal of NGF and serum (trophic withdrawal), rotenone, and glutamate |
| 07/01/2004 | US20040127467 Synthesis of pancratistatin prodrugs |
| 07/01/2004 | US20040127466 treatment and prevention of bone diseases in humans, including osteoporosis in postmenopausal women, Paget's Disease and hypercalcemia, by administration of a bisphosphonate in an inhalation form |
| 07/01/2004 | US20040127464 potent, selective and safe inhibitors of the Ca2+-activated potassium channel |
| 07/01/2004 | US20040127463 Uncomplexed cyclodextrin compositions for odor control |
| 07/01/2004 | US20040127462 Anilide and cyclodextrin complexes, their preparation and their use as medicine in particular for treating dyslipidemiae |
| 07/01/2004 | US20040127460 Use of pullulan as a slowly digested carbohydrate |
| 07/01/2004 | US20040127458 Beta-glucan containing compositions, methods for manufacturing beta-glucans, and for manufacturing and using beta-glucans and conjugates thereof as vaccine adjuvants |
| 07/01/2004 | US20040127457 uses of various molecules inhibiting heparanase such as sulfated polysaccharides |
| 07/01/2004 | US20040127456 an antiendotoxin compound is administered (e.g., intravenously) to a patient, before, during, and/or after surgery |
| 07/01/2004 | US20040127455 Muscosal immunoregulatory agent and its use |
| 07/01/2004 | US20040127454 Use of 5-substituted nucleosides and/or prodrugs thereof in the resistance-free treatment of infectious diseases |
| 07/01/2004 | US20040127453 treating a patient with a protein tyrosine kinase inhibitor in combination with a DNA methylation inhibitor |
| 07/01/2004 | US20040127452 C2,5'-disubstituted and N6,C2,5'-trisubstituted adenosine derivatives and pharmaceutical compositions containing them |
| 07/01/2004 | US20040127443 Novel PPAR ligands that do not cause fluid retention, edema or congestive heart failure |
| 07/01/2004 | US20040127442 Oligonucleotides for treating proliferative disorders |
| 07/01/2004 | US20040127441 Compositions and Methods for Treatment of Prostate and Other Cancers |
| 07/01/2004 | US20040127440 osteoporosis, osteopenia and Paget's disease therapy and prevention; administering a compound that lowers NPY level in blood serum |
| 07/01/2004 | US20040127437 Combined therapeutical treatment of hyperproliferative diseases |
| 07/01/2004 | US20040127436 1,3,5-Triazines for treatment of viral diseases |
| 07/01/2004 | US20040127435 Uses for inhibitors of inosine monophosphate dehydrogenase |
| 07/01/2004 | US20040127434 inhibitors of lipolysis, as cardioprotective agents or they may be of value in the therapy of diabetes |
| 07/01/2004 | US20040127433 Erythromycin derivative and medicament comprising the same |
| 07/01/2004 | US20040127431 for example, benign prostate hyperplasia (BPH), fibroplastic dysplasia of the breast, fibroplastic growth in the uterus or fibroplastic growth in the cervix |
| 07/01/2004 | US20040127429 glycolipid ligand for natural killer T (NKT) cells; synthetic analogs of alpha -C-galactosylceramides |
| 07/01/2004 | US20040127428 Use of D-ribose, including as a topical vehicle, to promote faster healing, including from surgical procedures |
| 07/01/2004 | US20040127425 Control of nitric oxide bioactivity by perfluorocarbons |
| 07/01/2004 | US20040127424 Inhibitors of cruzipain and other cysteine proteases |
| 07/01/2004 | US20040127419 Methods of using truncated glial cell line-derived neurotrophic factor |
| 07/01/2004 | US20040127413 for treatment of malnourished subjects or those in hypercatabolism condition |
| 07/01/2004 | US20040127404 Methods for treating autoimmune diseases |
| 07/01/2004 | US20040127402 Injectible composition and method for treating degenerative animal joints |
| 07/01/2004 | US20040127401 CA125 gene and its use for diagnostic and therapeutic interventions |
| 07/01/2004 | US20040127395 Use of histamine H4 receptor modulators for the treatment of allergy and asthma |
| 07/01/2004 | US20040127389 Effervescent solid composition of matter |
| 07/01/2004 | US20040126870 Ncc2705-the genome of a bifodobacterium |
| 07/01/2004 | US20040126863 Comprises amino acid sequences for use in identifying modulators for diagnosis and treatment of respiratory and diabetes-induced peripheral vascular diseases; mimetics |
| 07/01/2004 | US20040126862 Comprises nucleotide sequences coding protein of urogenital system for identifying moduators for treatment of cell proliferative and metastatic disorders |
| 07/01/2004 | US20040126861 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 07/01/2004 | US20040126828 Methods of diagnosing and treating pre-eclampsia or eclampsia |
| 07/01/2004 | US20040126816 Using blood coagulation factor to identify antibodies which modulate, prevent and treat tumors, inflammation, septic shock, hypotension and adult respiratory distress syndrome |
| 07/01/2004 | US20040126799 First nucleotide sequence comprises adenine residue at position 1033 or equivalent; reducing disease treatment side effects |
| 07/01/2004 | US20040126791 Compositions and methods for treating trail-resistant cancer cells |
| 07/01/2004 | US20040126461 Composition for enhancing physical performance |
| 07/01/2004 | US20040126460 Nutritional mineral supplements from plant ash |
| 07/01/2004 | US20040126448 Rapid composition with cocoa and vehicle for administering by mouthfor sexual dysfunction with sweeteners, emulsifiers, solubilizers and flavors |
| 07/01/2004 | US20040126440 Mixture of water, glycerol, cranberry juice, methylsulfonyl methane, oils, hydroxyethylcellulose and surfactant |
| 07/01/2004 | US20040126439 Polar extract of plants for hepatoprotection with drugs for treatment of diarrhea |
| 07/01/2004 | US20040126436 Mixture of bicarbonate and enzyme for rermoval of ear wax from ear canal |
| 07/01/2004 | US20040126433 Enhancing the photostable silver in medical equipment |
| 07/01/2004 | US20040126432 Blood flow enhancer and inflamation reducer, anticholesterol agents and oxidation reduction |
| 07/01/2004 | US20040126431 Method for preparing microspheres containing a water-soluble substance |
| 07/01/2004 | US20040126430 includes capsaicin; patches |
| 07/01/2004 | US20040126429 bactericides comprising potassium clavulanate and amoxycillin; bilayer time-release tablets |
| 07/01/2004 | US20040126428 comprises opiates; |
| 07/01/2004 | US20040126426 comprises paclitaxel, cisplatin, and hyaluronic acids; bioresorption; radiotherapy; for treatment of cancer |
| 07/01/2004 | US20040126424 comprises stiffening agents for ameliorating side effects associated with adminstration of lipase inhibitors (anal leakage of undigested fat or oil); for treatment of diabetes |
| 07/01/2004 | US20040126423 Pharmaceutical formulation |
| 07/01/2004 | US20040126420 phosphatidylcholine, sphingomyelin, phosphatidyl ethanolamine, phosphatidyl serine, phosphatidyl inositol, and cholesterol; for removal of extra-/intra- vascular fibrin clots/adhesions; for use during surgery; for treatment of otitis |
| 07/01/2004 | US20040126418 7-alpha-methyl-19-nortestosterone (MENT); androgens; improved bioavailability |
| 07/01/2004 | US20040126417 Transdermal buprenorphine to treat pain in sickle cell crisis |
| 07/01/2004 | US20040126416 Transdermal bupreorphine dosage regimen for analgesia |
| 07/01/2004 | US20040126415 such as (S)-6,8-dichloro-2-(trifluoromethyl)-2H-1-benzopyran-3-carboxylic acid; adhesive coated sheets |
| 07/01/2004 | US20040126414 Methods and compositions for treating and preventing ear infections |
| 07/01/2004 | US20040126408 Bioerodible film for ophthalmic drug delivery |
| 07/01/2004 | US20040126400 Delivery of therapeutic compounds via microparticles or microbubbles |
| 07/01/2004 | US20040126391 Meningococcal antigens |
| 07/01/2004 | US20040126385 Methods and compositions for screening, diagnosing, or treating NF-kappaB related disease |
| 07/01/2004 | US20040126380 Administering a neurotoxin ; therapy for enlargement of prostate gland |
| 07/01/2004 | US20040126379 Complex containing antibody and cytotoxic compound |
| 07/01/2004 | US20040126368 Method of alleviating chronic pain via peripheral inhibition of neurotransmitter synthesis |
| 07/01/2004 | US20040126367 Oxidation resistance; storage at low temperature; overcoated with liposomes from soybean lecithin |
| 07/01/2004 | US20040126366 Autism, attention deficit , obsessive complusive disorders , mental retardation |
| 07/01/2004 | US20040126364 Antiinflammatory agents; genetic engineered interleukins; oral diseases |